Form4insider filings, from the source

Insider · CIK 0001668775

Kenneth R Pitzer

Files at: TBPH. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Feb 20, 2019 FForm 4 →Feb 22, 6:18 pm ESTTheravance Biopharma, Inc.TBPH3,674$27.00$99,198266,650— plan?
Feb 5, 2019 AForm 4 →Feb 7, 5:47 pm ESTTheravance Biopharma, Inc.TBPH112,250——270,324— plan?
Nov 20, 2018 FForm 4 →Nov 21, 5:45 pm ESTTheravance Biopharma, Inc.TBPH3,908$24.79$96,879158,074— plan?
Aug 20, 2018 FForm 4 →Aug 22, 7:34 pm EDTTheravance Biopharma, Inc.TBPH5,043$26.95$135,909161,982— plan?
May 20, 2018 FForm 4 →May 22, 7:02 pm EDTTheravance Biopharma, Inc.TBPH18,779$24.31$456,517167,025— plan?
May 14, 2018 AForm 4 →May 16, 7:04 pm EDTTheravance Biopharma, Inc.TBPH33,750——185,804— plan?
Feb 20, 2018 FForm 4 →Feb 22, 5:40 pm ESTTheravance Biopharma, Inc.TBPH4,252$29.09$123,691152,054— plan?
Feb 12, 2018 AForm 4 →Feb 14, 6:21 pm ESTTheravance Biopharma, Inc.TBPH9,000——156,306— plan?
Nov 20, 2017 FForm 4 →Nov 22, 4:39 pm ESTTheravance Biopharma, Inc.TBPH5,014$28.58$143,300147,306— plan?
Aug 20, 2017 FForm 4 →Aug 22, 6:30 pm EDTTheravance Biopharma, Inc.TBPH5,013$27.40$137,356152,320— plan?
May 20, 2017 FForm 4 →May 23, 8:00 pm EDTTheravance Biopharma, Inc.TBPH5,014$36.83$184,666157,333— plan?
Feb 20, 2017 FForm 4 →Feb 22, 7:07 pm ESTTheravance Biopharma, Inc.TBPH10,030$33.78$338,813162,347— plan?
Feb 6, 2017 AForm 4 →Feb 8, 7:08 pm ESTTheravance Biopharma, Inc.TBPH9,000——172,377— plan?
Nov 20, 2016 FForm 4 →Nov 22, 6:04 pm ESTTheravance Biopharma, Inc.TBPH1,727$31.96$55,195163,377— plan?
Aug 20, 2016 FForm 4 →Aug 23, 7:25 pm EDTTheravance Biopharma, Inc.TBPH1,729$27.89$48,222165,104— plan?
May 20, 2016 FForm 4 →May 24, 8:00 pm EDTTheravance Biopharma, Inc.TBPH1,728$20.55$35,510166,833— plan?
Mar 15, 2016 AForm 4 →Mar 17, 7:06 pm EDTTheravance Biopharma, Inc.TBPH105,000——168,561— plan?

Reported trades — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.